• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

渗透保护剂对预防和治疗小鼠干眼的疗效。

Efficacy of osmoprotectants on prevention and treatment of murine dry eye.

机构信息

School of Ophthalmology and Optometry, Wenzhou Medical College, Wenzhou, China.

出版信息

Invest Ophthalmol Vis Sci. 2013 Sep 19;54(9):6287-97. doi: 10.1167/iovs.13-12081.

DOI:10.1167/iovs.13-12081
PMID:23970467
Abstract

PURPOSE

To evaluate the efficacy of osmoprotectants on prevention and treatment of dry eye in a murine model.

METHODS

Dry eye was induced in mice by using an intelligently controlled environmental system (ICES). Osmoprotectants betaine, L-carnitine, erythritol, or vehicle (PBS) were topically administered to eyes four times daily following two schedules: schedule 1 (modeling prevention): dosing started at the beginning of housing in ICES and lasted for 21 or 35 days; schedule 2 (modeling treatment): dosing started after ICES-housed mice developed dry eye (day 21), continuing until day 35. Treatment efficacy was evaluated for corneal fluorescein staining; corneal epithelial apoptosis by TUNEL and caspase-3 assays; goblet cell numbers by PAS staining; and expression of inflammatory mediators, TNF-α, IL-17, IL-6, or IL-1β by using RT-PCR on days 0, 14, 21, and/or 35.

RESULTS

Compared with vehicle, prophylactic administration of betaine, L-carnitine, or erythritol significantly decreased corneal staining and expression of TNF-α and IL-17 on day 21 (schedule 1). Treatment of mouse dry eye with osmoprotectants significantly reduced corneal staining on day 35 compared with day 21 (schedule 2). Relative to vehicle, L-carnitine treatment of mouse dry eye for 14 days (days 21 to 35) resulted in a significant reduction in corneal staining, number of TUNEL-positive cells, and expression of TNF-α, IL-17, IL-6, or IL-1β, as well as significantly increased the number of goblet cells.

CONCLUSIONS

Topical application of betaine, L-carnitine, or erythritol systematically limited progression of environmentally induced dry eye. L-carnitine can also reduce the severity of such dry-eye conditions.

摘要

目的

评估渗透调节剂对环境诱导性干眼症小鼠模型的预防和治疗效果。

方法

使用智能环境控制系统(ICES)诱导小鼠干眼症。在两种方案下,每日四次向眼部局部施用渗透调节剂甜菜碱、左旋肉碱、赤藓糖醇或载体(PBS):方案 1(模型预防):在 ICES 饲养开始时开始给药,持续 21 或 35 天;方案 2(模型治疗):在 ICES 饲养的小鼠出现干眼症(第 21 天)后开始给药,持续至第 35 天。通过角膜荧光素染色、TUNEL 和 caspase-3 检测评估角膜上皮细胞凋亡、PAS 染色评估杯状细胞数量,以及在第 0、14、21 和/或 35 天使用 RT-PCR 评估炎症介质 TNF-α、IL-17、IL-6 或 IL-1β的表达。

结果

与载体相比,预防性给予甜菜碱、左旋肉碱或赤藓糖醇可显著降低第 21 天(方案 1)的角膜染色和 TNF-α和 IL-17 的表达。与第 21 天相比,用渗透调节剂治疗小鼠干眼症可显著降低第 35 天的角膜染色(方案 2)。与载体相比,用左旋肉碱治疗 14 天(第 21 天至第 35 天)的干眼症小鼠可显著减少角膜染色、TUNEL 阳性细胞数以及 TNF-α、IL-17、IL-6 或 IL-1β的表达,同时显著增加杯状细胞数量。

结论

局部应用甜菜碱、左旋肉碱或赤藓糖醇可系统性地限制环境诱导性干眼症的进展。左旋肉碱还可以减轻这种干眼症的严重程度。

相似文献

1
Efficacy of osmoprotectants on prevention and treatment of murine dry eye.渗透保护剂对预防和治疗小鼠干眼的疗效。
Invest Ophthalmol Vis Sci. 2013 Sep 19;54(9):6287-97. doi: 10.1167/iovs.13-12081.
2
Therapeutic effects of epidermal growth factor on benzalkonium chloride-induced dry eye in a mouse model.表皮生长因子对苯扎氯铵诱导的小鼠干眼的治疗作用。
Invest Ophthalmol Vis Sci. 2012 Jan 20;53(1):191-7. doi: 10.1167/iovs.11-8553.
3
Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system.海藻糖滴眼液对智能控制环境系统诱导的小鼠干眼症的治疗效果
Mol Vis. 2012;18:317-29. Epub 2012 Feb 4.
4
Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.在小鼠模型中,通过局部应用整合素α4拮抗剂GW559090可改善干燥综合征相关的干眼。
Exp Eye Res. 2016 Feb;143:1-8. doi: 10.1016/j.exer.2015.10.008. Epub 2015 Oct 14.
5
A murine model of dry eye induced by an intelligently controlled environmental system.一种由智能控制环境系统诱导的小鼠干眼模型。
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1386-91. doi: 10.1167/iovs.07-0744.
6
Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis.海藻糖通过抑制细胞凋亡来预防实验性小鼠干眼症的眼表疾病。
Exp Eye Res. 2009 Sep;89(3):311-8. doi: 10.1016/j.exer.2009.03.015. Epub 2009 Apr 2.
7
Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress.左旋肉碱、赤藓糖醇和甜菜碱对暴露于高渗应激的原代人角膜上皮细胞中促炎标志物的影响。
Curr Eye Res. 2015 Jul;40(7):657-67. doi: 10.3109/02713683.2014.957776. Epub 2014 Oct 1.
8
Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model.局部用多西环素在苯扎氯铵诱导的小鼠干眼模型中的治疗作用
Invest Ophthalmol Vis Sci. 2014 May 6;55(5):2963-74. doi: 10.1167/iovs.13-13577.
9
The leaves of Diospyros kaki exert beneficial effects on a benzalkonium chloride-induced murine dry eye model.柿叶对苯扎氯铵诱导的小鼠干眼模型具有有益作用。
Mol Vis. 2016 Apr 2;22:284-93. eCollection 2016.
10
Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model.一种新型人工泪液在动物模型中预防和治疗干眼的评估。
J Ocul Pharmacol Ther. 2015 Nov;31(9):525-30. doi: 10.1089/jop.2015.0042. Epub 2015 Aug 31.

引用本文的文献

1
The alterations of ocular surface metabolism and the related immunity inflammation in dry eye.干眼患者眼表代谢及相关免疫炎症的改变
Adv Ophthalmol Pract Res. 2024 Aug 14;5(1):1-12. doi: 10.1016/j.aopr.2024.08.003. eCollection 2025 Feb-Mar.
2
iHA318 Improves Dry Eye Symptoms by Mitigating Ocular Surface Damage in a Mouse Model.iHA318通过减轻小鼠模型的眼表损伤改善干眼症状。
Microorganisms. 2024 Jun 27;12(7):1306. doi: 10.3390/microorganisms12071306.
3
Ectoine Enhances Mucin Production Via Restoring IL-13/IFN-γ Balance in a Murine Dry Eye Model.
四氢嘧啶通过恢复小鼠干眼模型中的 IL-13/IFN-γ 平衡来增强粘蛋白的产生。
Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):39. doi: 10.1167/iovs.65.6.39.
4
Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents.通过将合成磷脂囊泡与透明质酸和渗透保护剂联合应用来增强拉坦前列素的降压作用。
Drug Deliv Transl Res. 2024 Oct;14(10):2804-2822. doi: 10.1007/s13346-024-01584-z. Epub 2024 Apr 11.
5
Tear and Saliva Metabolomics in Evaporative Dry Eye Disease in Females.女性蒸发型干眼病患者的泪液和唾液代谢组学
Metabolites. 2023 Nov 2;13(11):1125. doi: 10.3390/metabo13111125.
6
L-Carnitine Suppresses Transient Receptor Potential Vanilloid Type 1 Activation in Human Corneal Epithelial Cells.左旋肉碱抑制人角膜上皮细胞中瞬时受体电位香草素 1 型的激活。
Int J Mol Sci. 2023 Jul 23;24(14):11815. doi: 10.3390/ijms241411815.
7
Involvement of endoplasmic reticulum stress in trigeminal ganglion corneal neuron injury in dry eye disease.内质网应激参与干眼疾病中三叉神经节角膜神经元损伤
Front Mol Neurosci. 2023 Mar 24;16:1083850. doi: 10.3389/fnmol.2023.1083850. eCollection 2023.
8
A Critical Appraisal of the Physicochemical Properties and Biological Effects of Artificial Tear Ingredients and Formulations.人工泪液成分和配方的物理化学性质及生物学效应的批判性评价。
Int J Mol Sci. 2023 Feb 1;24(3):2758. doi: 10.3390/ijms24032758.
9
Recent Advances in Hydrogels for the Diagnosis and Treatment of Dry Eye Disease.用于干眼症诊断与治疗的水凝胶的最新进展
Gels. 2022 Dec 11;8(12):816. doi: 10.3390/gels8120816.
10
Dry eye syndrome: comprehensive etiologies and recent clinical trials.干眼综合征:全面病因与近期临床试验。
Int Ophthalmol. 2022 Oct;42(10):3253-3272. doi: 10.1007/s10792-022-02320-7. Epub 2022 Jun 9.